6915. Various prescription drugs.    (F.D.C. No. 46739.    S. Nos. 12-881/3 T, 12- 
886 T,   12-888 T, 12-892 T, 12-894 T, 12-898/900 T.)
QTTANTTTT: Various quantities of tablets and capsules at Chicago, Ill., in pos- 
session of Solomon Cooper Drugs.
SHIPPED:   On unknown dates, by various drug handlers.
RESULTS OP INVESTIGATION: The articles consisted of quantities of prescrip- 
tion drugs repacked from physicians' samples into containers having labels 
bearing brand names indicative of manufacture outside the State of Illinois, 
and the words "Physician's Sample," "Physician's Professional Package," 
"Professional Sample," "Complimentary," or similar wording; and quantities 
of prescription drugs which were not yet repacked, originally intended for 
use as samples, and bearing labels containing the words "Professional Sam- 
ple," "Physician's Professional Package," "Sample Not To Be Sold," "Com- 
plimentary," or similar wording, and the names and addresses of the manu- 
facturers, packers, or distributors located outside the State of Illinois-
LIBELED:   11-21-61, N. Dist. HI.
CHARGE: 502(a)-while held for sale, the sample legends appearing on the 
labels affixed to the articles were false and misleading as applied to the 
articles in the possession of the repacker and intended for sale and not 
intended for use as "complimentary-not for sale" samples for physicians and 
others lawfully engaged in dispensing prescription drugs, and the labeling of 
a number of articles whose expiration dates had expired also was misleading 
as applied to the articles which were not suitable for use after their expiration 
date had expired; 502(b)-a number of the articles of drug failed to bear a 
label containing (1) the name and place of business of the manufacturer.
packer, or distributor and (2) an accurate statement of the quantity of con- 
tents; 502(f)(1)-the labeling of a number of the articles failed to bear 
adequate directions for use and they were not exempt from that requirement 
since they were subject to the provisions of 503(b) (1) and their labels failed 
to bear an identifying lot or control number from which it was possible to 
determine the complete manufacturing history as is required by regulations, 
and the labeling of a number of the articles whose expiration dates had 
expired also failed to bear adequate directions for use after their expiration 
dates; and 503(b)(4)-the articles of drug were subject to the provisions 
of 503(b) (1) and the labels of a number of the articles failed to bear the 
statement "Caution: Federal law prohibits dispensing without prescription."
DISPOSITION :   12-27-61. Default-destruction.
DRUGS AND DEVICES ACTIONABLE BECAUSE OF FAILURE TO BEAR 
ADEQUATE DIRECTIONS OR WARNING STATEMENTS*